Yiwei Tong

483 total citations
33 papers, 302 citations indexed

About

Yiwei Tong is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Yiwei Tong has authored 33 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 20 papers in Cancer Research and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Yiwei Tong's work include Breast Cancer Treatment Studies (17 papers), HER2/EGFR in Cancer Research (10 papers) and Breast Lesions and Carcinomas (9 papers). Yiwei Tong is often cited by papers focused on Breast Cancer Treatment Studies (17 papers), HER2/EGFR in Cancer Research (10 papers) and Breast Lesions and Carcinomas (9 papers). Yiwei Tong collaborates with scholars based in China, Canada and United Kingdom. Yiwei Tong's co-authors include Kunwei Shen, Xiaosong Chen, Weiguo Chen, Jianrong He, Ou Huang, Jiayi Wu, Yujie Lu, Zhuoxuan Li, Li Zhu and Xiaochun Fei and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Annals of Oncology.

In The Last Decade

Yiwei Tong

32 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yiwei Tong China 12 169 138 72 72 51 33 302
Valentina Magri Italy 11 207 1.2× 132 1.0× 66 0.9× 56 0.8× 63 1.2× 28 345
Antonia Márquez Spain 10 294 1.7× 134 1.0× 107 1.5× 71 1.0× 99 1.9× 15 444
C.F.J.M. Blanken-Peeters Netherlands 8 166 1.0× 178 1.3× 43 0.6× 51 0.7× 41 0.8× 12 297
Zhimin Shao China 12 112 0.7× 187 1.4× 100 1.4× 62 0.9× 36 0.7× 23 362
Bianca Grosser Germany 13 155 0.9× 119 0.9× 75 1.0× 49 0.7× 123 2.4× 35 352
Lauren Nye United States 9 270 1.6× 115 0.8× 58 0.8× 34 0.5× 76 1.5× 37 369
Carmine Valenza Italy 10 185 1.1× 87 0.6× 76 1.1× 65 0.9× 86 1.7× 47 311
Dominique J P van Uden Netherlands 7 143 0.8× 136 1.0× 41 0.6× 44 0.6× 76 1.5× 15 277
Long-Zi Liu China 8 109 0.6× 81 0.6× 96 1.3× 108 1.5× 74 1.5× 8 325
Benlong Yang China 13 169 1.0× 220 1.6× 77 1.1× 45 0.6× 60 1.2× 40 427

Countries citing papers authored by Yiwei Tong

Since Specialization
Citations

This map shows the geographic impact of Yiwei Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiwei Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiwei Tong more than expected).

Fields of papers citing papers by Yiwei Tong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiwei Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiwei Tong. The network helps show where Yiwei Tong may publish in the future.

Co-authorship network of co-authors of Yiwei Tong

This figure shows the co-authorship network connecting the top 25 collaborators of Yiwei Tong. A scholar is included among the top collaborators of Yiwei Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiwei Tong. Yiwei Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tong, Yiwei, Xi Sun, Anqi Li, et al.. (2025). Clinicopathological and molecular significance of HER2-low expression in Asian women with triple-negative breast cancer. Therapeutic Advances in Medical Oncology. 17. 22797819–22797819. 1 indexed citations
2.
Chen, Xiaosong, Jiahui Huang, Yiwei Tong, et al.. (2024). Trastuzumab, pertuzumab and nab-paclitaxel plus pyrotinib or not in neoadjuvant treatment of HER2-positive breast cancer: A multi-center, randomized, open-label, phase II study.. Journal of Clinical Oncology. 42(16_suppl). e12634–e12634.
3.
Wang, Zheng, Yujie Lu, Anqi Li, et al.. (2024). Association between homologous recombination deficiency status and carboplatin treatment response in early triple-negative breast cancer. Breast Cancer Research and Treatment. 208(2). 429–440. 2 indexed citations
4.
Ding, Shuning, Q. L. Niu, Qingchen Zhu, et al.. (2023). Single‐cell atlas reveals a distinct immune profile fostered by T cell‐B cell crosstalk in triple negative breast cancer. Cancer Communications. 43(6). 661–684. 29 indexed citations
5.
Tong, Yiwei, et al.. (2023). Ki67 increase after core needle biopsy associated with worse disease outcome in HER2-negative breast cancer patients. Scientific Reports. 13(1). 2489–2489. 5 indexed citations
6.
Lu, Yujie, Yiwei Tong, Xiaochun Fei, Xiaosong Chen, & Kunwei Shen. (2023). Clinical characteristics, tumor‐infiltrating lymphocytes, and prognosis in HER2‐low breast cancer: A comparison study with HER2‐zero and HER2‐positive disease. Cancer Medicine. 12(15). 16264–16278. 5 indexed citations
7.
Tong, Yiwei, Jiahui Huang, Jing Yu, et al.. (2022). Association of tumor immune microenvironment profiling and 21-gene recurrence assay in early breast cancer patients. European journal of medical research. 27(1). 293–293. 4 indexed citations
8.
Huang, Jiahui, Yiwei Tong, Jin Hong, et al.. (2022). Neoadjuvant docetaxel, epirubicin, and cyclophosphamide with or without metformin in breast cancer patients with metabolic abnormality: results from the randomized Phase II NeoMET trial. Breast Cancer Research and Treatment. 197(3). 525–533. 11 indexed citations
9.
10.
Zhu, Yifei, Tiange Wang, Yiwei Tong, Xiaosong Chen, & Kunwei Shen. (2021). 21-Gene Recurrence Assay Associated With Favorable Metabolic Profiles in HR-Positive, HER2-Negative Early-Stage Breast Cancer Patients. Frontiers in Endocrinology. 12. 725161–725161. 2 indexed citations
11.
Lu, Yujie, Yiwei Tong, Jiahui Huang, et al.. (2021). Diverse Distribution and Gene Expression on the 21-Gene Recurrence Assay in Breast Cancer Patients with Locoregional Recurrence Versus Distant Metastasis. Cancer Management and Research. Volume 13. 6279–6289. 3 indexed citations
12.
Lu, Yujie, Yiwei Tong, Xiaosong Chen, & Kunwei Shen. (2021). Association of Biomarker Discrepancy and Treatment Decision, Disease Outcome in Recurrent/Metastatic Breast Cancer Patients. Frontiers in Oncology. 11. 638619–638619. 14 indexed citations
13.
Montagna, Giacomo, Yiwei Tong, Mathilde Ritter, et al.. (2021). Predictors of Nodal Pathological Complete Response in Asian Women with Stage II–III Node-Positive Breast Cancer. Oncology. 99(6). 359–364. 1 indexed citations
14.
Tong, Yiwei, Jifu Mao, Ying Mao, et al.. (2020). Limb salvage after aneurysmal degeneration of a cryopreserved vein allograft: Searching the autologous veins of the arm is worth the effort. Morphologie. 104(346). 202–213. 2 indexed citations
15.
Tong, Yiwei, Jiayi Wu, Ou Huang, et al.. (2020). IGF-1 Interacted With Obesity in Prognosis Prediction in HER2-Positive Breast Cancer Patients. Frontiers in Oncology. 10. 550–550. 14 indexed citations
16.
Lu, Yujie, Yiwei Tong, Jiahui Huang, et al.. (2020). Primary 21-Gene Recurrence Score and Disease Outcome in Loco-Regional and Distant Recurrent Breast Cancer Patients. Frontiers in Oncology. 10. 1315–1315. 3 indexed citations
17.
Tong, Yiwei, et al.. (2020). Prolonged Time to Adjuvant Chemotherapy Initiation Was Associated with Worse Disease Outcome in Triple Negative Breast Cancer Patients. Scientific Reports. 10(1). 7029–7029. 19 indexed citations
18.
Mao, Jifu, Yiwei Tong, Lucie Germain, et al.. (2019). Donkey pericardium compares favorably with commercial xenopericardia used in the manufacture of transcatheter heart valves. Artificial Organs. 43(10). 976–987. 7 indexed citations
19.
Tong, Yiwei, Jiayi Wu, Ou Huang, et al.. (2019). 21-Gene Recurrence Score and Adjuvant Chemotherapy Decision for Breast Cancer Patients with Positive Lymph Nodes. Scientific Reports. 9(1). 13123–13123. 11 indexed citations
20.
Tong, Yiwei, et al.. (2019). Short-term outcomes of the over-the-scope clip proctology system for rectovaginal fistula repair: a prospective study. Techniques in Coloproctology. 23(3). 245–249. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valentina Magri Breakdown of academic impact, for papers by Antonia Márquez Breakdown of academic impact, for papers by C.F.J.M. Blanken-Peeters Breakdown of academic impact, for papers by Zhimin Shao Breakdown of academic impact, for papers by Bianca Grosser Breakdown of academic impact, for papers by Lauren Nye Breakdown of academic impact, for papers by Carmine Valenza Breakdown of academic impact, for papers by Dominique J P van Uden Breakdown of academic impact, for papers by Long-Zi Liu Breakdown of academic impact, for papers by Benlong Yang
Rankless by CCL
2026